|
Theranostics 2018
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancersDOI: 10.7150/thno.24487 Abstract: Purpose: To demonstrate the safety and feasibility of leveraging therapeutic antibodies for surgical imaging.
|